🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was to find out if patients with Relapsing Remitting Multiple Sc...
Status
Completed
Location
Coordinating Research Site
Start Date
1999-11
Trial ID
NCT00534261
Treatments Being Tested
The purpose of the study is to determine if Interferon-alfa is effective an...
Status
Completed
Location
Multiple Locations
Start Date
2010-07
Trial ID
NCT01171209
Treatments Being Tested
The primary objective of the study is to assess the clinical efficacy of Re...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2004-02-16
Trial ID
NCT00078338
DisCoVeRy is a randomized controlled trial among adults (≥18-year-old) hosp...
Status
Completed
Location
Medizinische Universität Innsbruck
Start Date
2020-03-22
Trial ID
NCT04315948
The purpose of this study is to determine whether RNS60 is effective in the...
Status
Withdrawn
Location
Mt. Sinai School of Medicine
Start Date
TBD
Trial ID
NCT01714089
Treatments Being Tested
The goal of this study was to evaluate the safety, tolerability and effecti...
Status
Completed
Location
Research Site
Start Date
2006-11-30
Trial ID
NCT00436826
Treatments Being Tested
People with multiple sclerosis (MS) often experience problems with cognitiv...
Status
Unknown
Location
The Research and Education Institute of Alta Bates Summit Medical Center
Start Date
2009-03
Trial ID
NCT00914758
This 1-arm, open-label, multicentric, observational study aims to collect s...
Status
Completed
Location
Bupa Home Healthcare
Start Date
2007-01
Trial ID
NCT01080573
There are two standard and a few second line treatments for RRMS. Since the...
Status
Unknown
Location
Department of Neurology
Start Date
2015-01
Trial ID
NCT02364986
The aim of the study is to assess the safety of inhaled SNG001 and the abil...
Status
Completed
Location
Celerion
Start Date
2018-01-29
Trial ID
NCT03570359
Treatments Being Tested